Letters
Incidence, Predictors, and Outcome of Patients Developing Infective Endocarditis Following Transfemoral Transcatheter Aortic Valve Replacement

https://doi.org/10.1016/j.jacc.2016.03.588Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Please note: Dr. Holzhev has received support from Symetis and Medtronic. Dr. Leontyev has received support from St. Jude Medical and Medtronic. Dr. Linke has received consulting fees and grant support from Medtronic; has received speaking honoraria from St. Jude Medical, Claret Medical, Boston Scientific, Bard, and Edwards Lifesciences, and Symetis; and owns equity in Claret Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. The authors would like to thank Jennifer Adam, Kathrin Luderer, Carola Döhnert, and Jaqueline Föhlisch for their data management.